Virulence of Pseudomonas aeruginosa in Cystic Fibrosis: Relationships between Normoxia and Anoxia Lifestyle

被引:2
|
作者
Papa, Rosanna [1 ]
Imperlini, Esther [2 ]
Trecca, Marika [1 ]
Paris, Irene [1 ]
Vrenna, Gianluca [3 ,4 ]
Artini, Marco [1 ]
Selan, Laura [1 ]
机构
[1] Sapienza Univ, Dept Publ Hlth & Infect Dis, p Aldo Moro 5, I-00185 Rome, Italy
[2] Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst, I-0100 Viterbo, Italy
[3] Childrens Hosp, Res Unit Diagnost & Management Innovat, I-00165 Rome, Italy
[4] Inst Res Bambino Gesu, I-00165 Rome, Italy
来源
ANTIBIOTICS-BASEL | 2024年 / 13卷 / 01期
关键词
oxygen concentration; antimicrobial resistance; biofilm; pyocyanin; pyoverdine; motility; proteases; PYOCYANIN PRODUCTION; ADAPTATION;
D O I
10.3390/antibiotics13010001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The airways of cystic fibrosis (CF) patients are colonized by many pathogens and the most common is Pseudomonas aeruginosa, an environmental pathogen that is able to infect immunocompromised patients thanks to its ability to develop resistance to conventional antibiotics. Over 12% of all patients colonized by P. aeruginosa harbour multi-drug resistant species. During airway infection in CF, P. aeruginosa adopts various mechanisms to survive in a hostile ecological niche characterized by low oxygen concentration, nutrient limitation and high osmotic pressure. To this end, P. aeruginosa uses a variety of virulence factors including pigment production, biofilm formation, motility and the secretion of toxins and proteases. This study represents the first report that systematically analyzes the differences in virulence features, in normoxia and anoxia, of clinical P. aeruginosa isolated from CF patients, characterized by multi- or pan-drug antibiotic resistance compared to antibiotic sensitive strains. The virulence features, such as biofilm formation, protease secretion and motility, are highly diversified in anaerobiosis, which reflects the condition of chronic CF infection. These findings may contribute to the understanding of the real-world lifestyle of pathogens isolated during disease progression in each particular patient and to assist in the design of therapeutic protocols for personalized medicine.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis
    J. Manos
    H. Hu
    B. R. Rose
    C. E. Wainwright
    I. B. Zablotska
    J. Cheney
    L. Turnbull
    C. B. Whitchurch
    K. Grimwood
    C. Harmer
    S. N. Anuj
    C. Harbour
    European Journal of Clinical Microbiology & Infectious Diseases, 2013, 32 : 1583 - 1592
  • [22] A gacS Deletion in Pseudomonas aeruginosa Cystic Fibrosis Isolate CHA Shapes Its Virulence
    Sall, Khady Mayebine
    Casabona, Maria Guillermina
    Bordi, Christophe
    Huber, Philippe
    de Bentzmann, Sophie
    Attree, Ina
    Elsen, Sylvie
    PLOS ONE, 2014, 9 (04):
  • [23] LONGITUDINAL-STUDIES OF VIRULENCE FACTORS OF PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS
    BURKE, V
    ROBINSON, JO
    RICHARDSON, CJL
    BUNDELL, CS
    PATHOLOGY, 1991, 23 (02) : 145 - 148
  • [24] Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis Strains
    Carullo, Gabriele
    Di Bonaventura, Giovanni
    Rossi, Sara
    Lupetti, Veronica
    Tudino, Valeria
    Brogi, Simone
    Butini, Stefania
    Campiani, Giuseppe
    Gemma, Sandra
    Pompilio, Arianna
    MOLECULES, 2023, 28 (18):
  • [25] Quorum Sensing and Virulence of Pseudomonas aeruginosa during Lung Infection of Cystic Fibrosis Patients
    Bjarnsholt, Thomas
    Jensen, Peter Ostrup
    Jakobsen, Tim Holm
    Phipps, Richard
    Nielsen, Anne Kirstine
    Rybtke, Morten Theil
    Tolker-Nielsen, Tim
    Givskov, Michael
    Hoiby, Niels
    Ciofu, Oana
    PLOS ONE, 2010, 5 (04):
  • [26] Pseudomonas aeruginosa and Children With Cystic Fibrosis COMMENT
    Sala, Marc A.
    Jain, Mane
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E2529 - E2530
  • [27] Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
    Kenny, S. L.
    Shaw, T. D.
    Downey, D. G.
    Moore, J. E.
    Rendall, J. C.
    Elborn, J. S.
    BMJ OPEN RESPIRATORY RESEARCH, 2013, 1 (01):
  • [28] Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis
    Cramer, Nina
    Wiehlmann, Lutz
    Tuemmler, Burkhard
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 300 (08) : 526 - 533
  • [29] Pseudomonas aeruginosa: a key problem in cystic fibrosis
    Pier, GB
    ASM NEWS, 1998, 64 (06): : 339 - +
  • [30] Ceramide in Pseudomonas aeruginosa Infections and Cystic Fibrosis
    Becker, Katrin Anne
    Grassme, Heike
    Zhang, Yang
    Gulbins, Erich
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2010, 26 (01) : 57 - 66